| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $320M | — | $373M | — | -14.2% |
| Op. Income | $20M | — | $20M | — | -2.5% |
| Gross Margin | 37.3% | — | 34.6% | — | 2.7pp |
| Net Margin | 4.9% | — | 4.3% | — | 0.6pp |
| EPS (Diluted) | $0.77 | — | $0.78 | — | -1.3% |
| Free Cash Flow | $34M | — | $847.0K | — | 3918.8% |
| Item | Amount |
|---|---|
| REVENUE | $320M |
| Cost of Revenue | $201M |
| GROSS PROFIT | $119M |
| R&D Expenses | $17M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $83M |
| Other Expenses | $0 |
| Operating Expenses | $100M |
| Cost & Expenses | $300M |
| OPERATING INCOME | $20M |
| Interest Income | $0 |
| Interest Expense | $10M |
| Other Income/Expenses | -$3M |
| INCOME BEFORE TAX | $17M |
| Income Tax Expense | $1M |
| Net Income from Continuing Ops | $16M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $16M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $16M |
| D&A | $12M |
| EBIT | $20M |
| EBITDA | $32M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $320M |
| Cost of Revenue | $201M |
| GROSS PROFIT | $119M |
| R&D Expenses | $17M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $83M |
| Other Expenses | $0 |
| Operating Expenses | $100M |
| Cost & Expenses | $300M |
| OPERATING INCOME | $20M |
| Interest Income | $0 |
| Interest Expense | $10M |
| Other Income/Expenses | -$3M |
| INCOME BEFORE TAX | $17M |
| Income Tax Expense | $1M |
| Net Income from Continuing Ops | $16M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $16M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $16M |
| D&A | $12M |
| EBIT | $20M |
| EBITDA | $32M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $16M |
| Depreciation & Amortization | $12M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | -$115.0K |
| Other Non-Cash Items | $11M |
| Change in Working Capital | -$4M |
| OPERATING CASH FLOW | $35M |
| Capital Expenditure | -$1M |
| Acquisitions (Net) | -$3M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $5M |
| NET CASH FROM INVESTING | $1M |
| Net Debt Issuance | -$16M |
| Common Stock Repurchased | -$19M |
| Common Dividends Paid | $0 |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | -$33M |
| FREE CASH FLOW | $34M |
| Net Change in Cash | $4M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $17M |
| Short-Term Investments | $0 |
| Net Receivables | $77M |
| Inventory | $69M |
| Other Current Assets | $11M |
| TOTAL CURRENT ASSETS | $174M |
| PP&E (Net) | $3M |
| Goodwill | $50M |
| Intangible Assets | $34M |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $7M |
| TOTAL NON-CURRENT ASSETS | $95M |
| TOTAL ASSETS | $269M |
| Account Payables | $25M |
| Short-Term Debt | $38M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $25M |
| TOTAL CURRENT LIABILITIES | $88M |
| Long-Term Debt | $46M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $7M |
| TOTAL NON-CURRENT LIABILITIES | $53M |
| TOTAL LIABILITIES | $141M |
| Common Stock | $19.0K |
| Additional Paid-In Capital | $229M |
| Retained Earnings | -$102M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $2M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $128M |
| Minority Interest | $0 |
| TOTAL EQUITY | $128M |
| TOTAL LIABILITIES & EQUITY | $269M |
| Total Debt | $84M |
| Net Debt | $67M |
